Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMW 2021 | COVID-19 in myeloma: what have we learnt?

Joaquin Martinez-Lopez, MD, PhD, of the Universidad Complutense de Madrid, Madrid, Spain, talks on the impact that the COVID-19 pandemic has had on the treatment and management of patients with multiple myeloma, and discusses what can be learnt from this. Dr Martinez-Lopez shares some preliminary data from studies investigating the severity and clinical outcomes for patients with multiple myeloma. Another study looked at real-world data from 80,000 patients globally, which found that patients with multiple myeloma were more likely to be diagnosed with COVID-19. This interview took place during the 18th International Myeloma Workshop (IMW 2021) congress.


Joaquin Martinez-Lopez, MD, PhD, has received grant support from BMS; and has performed consultancy work for BMS, Janssen, Novartis, GSK, Incyte, Roche and Astellas.